Cyclosporine A (CsA) is a widely used immunosuppressive agent that greatly reduces the
rates of kidney-, heart-, and liver-transplant rejection. However, CsA nephrotoxicity is a …

Background: Acute graft-versus-host disease (aGVHD) is a major complication following
hematopoietic stem cell transplantation (HSCT). Objective: This study aimed to explore the …

The recent study delves into the role of both liraglutide and/or resveratrol on the
nephropathic affection in rats treated with cyclosporine A (CsA). Rats were intoxicated with …

Objectives. This study aimed to investigate the effects of different triazole antifungal agents
on the blood concentration and dosage of cyclosporine (CsA) in patients with aplastic …

Purpose To explore the contribution of physiological characteristics to variability in
ciclosporin pharmacokinetics in hematopoietic stem cell transplantation patients. Methods …

Objectives To investigate the effects of multiple doses of baicalin (BG) on the
pharmacokinetics of ciclosporin (CsA) in rats and the potential mechanisms. Methods …

Purpose This study aimed to investigate the interactions between posaconazole (POS) and
intravenously/orally administered cyclosporine A (CsA) in allogeneic hematopoietic stem …

A 26-year-old woman developed symptoms of acute toxicity during cyclosporine (CsA)
therapy for graft-versus-host disease prophylaxis. The standard regimen included CsA in a …

This paper aims to study whether cyclosporine‐A (CSA) levels have an impact on the clinical
outcome of patients with T‐cell replete haploidentical allogeneic hematopoietic stem cell …

Cyclosporin A (CsA) is widely used as an immunosuppressor in the context of organ
transplantation or autoimmune disorders. Recent studies have revealed the detrimental …